Table 2.
Dose of risedronate (μg/kg/day) | 0 (n = 20) |
0.15 (n = 10) |
1.5 (n = 10) |
15 (n = 10) |
150 (n = 10) |
p valuea |
||
---|---|---|---|---|---|---|---|---|
Risedronate | Loading | Interaction | ||||||
Trabecular bone | ||||||||
Bone volume/tissue volume | ||||||||
Left control (%) | 16.6 ± 0.3 | 17.1 ± 0.4 | 17.7 ± 0.3 | 20.9 ± 0.6 | 21.3 ± 0.4 | < 0.001 | < 0.001 | 0.655 |
Right loaded (%) | 22.7 ± 0.5 | 22.6 ± 0.5 | 23.2 ± 0.6 | 26.4 ± 0.7 | 27.7 ± 0.8 | |||
Trabecular number | ||||||||
Left control (mm− 1) | 3.02 ± 0.05 | 3.07 ± 0.08 | 3.26 ± 0.06 | 3.66 ± 0.10 | 3.60 ± 0.08 | < 0.001 | < 0.001 | 0.697 |
Right loaded (mm− 1) | 3.38 ± 0.05 | 3.40 ± 0.10 | 3.53 ± 0.08 | 4.03 ± 0.10 | 4.04 ± 0.13 | |||
Trabecular thickness | ||||||||
Left control (μm) | 55.1 ± 0.5 | 55.7 ± 0.8 | 54.4 ± 0.6 | 57.3 ± 0.8 | 59.2 ± 0.9 | 0.009 | < 0.001 | 0.011 |
Right loaded (μm) | 67.1 ± 0.6 | 66.5 ± 0.9 | 65.8 ± 1.0 | 65.5 ± 0.8 | 68.6 ± 1.1 | |||
Cortical bone | ||||||||
Bone volume | ||||||||
Left control (mm3) | 0.380 ± 0.003 | 0.383 ± 0.003 | 0.366 ± 0.005 | 0.377 ± 0.007 | 0.372 ± 0.007 | 0.815 | < 0.001 | 0.725 |
Right loaded (mm3) | 0.481 ± 0.006 | 0.479 ± 0.006 | 0.476 ± 0.008 | 0.479 ± 0.009 | 0.481 ± 0.007 | |||
Periosteally enclosed volume | ||||||||
Left control (mm3) | 0.627 ± 0.005 | 0.614 ± 0.006 | 0.594 ± 0.008 | 0.611 ± 0.011 | 0.607 ± 0.012 | 0.111 | < 0.001 | 0.243 |
Right loaded (mm3) | 0.717 ± 0.005 | 0.713 ± 0.008 | 0.709 ± 0.006 | 0.704 ± 0.010 | 0.709 ± 0.007 | |||
Medullary volume | ||||||||
Left control (mm3) | 0.247 ± 0.003 | 0.231 ± 0.004 | 0.228 ± 0.005 | 0.234 ± 0.006 | 0.236 ± 0.007 | 0.096 | 0.085 | 0.030 |
Right loaded (mm3) | 0.237 ± 0.004 | 0.234 ± 0.006 | 0.234 ± 0.005 | 0.226 ± 0.007 | 0.228 ± 0.005 |
Mean ± SE.
Mixed model analysis including body weight.